Clinical Trial Update: Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of adding vildagliptin to continuous subcutaneous insulin infusion in adults with uncontrolled type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: T2DM | Phase 4 | Status: UNKNOWN